SPY334.19+5.46 1.66%
DIA275.90+4.20 1.55%
IXIC11,117.53+203.96 1.87%

Myriad Receives FDA Approval Of BRACAnalysis CDx As Companion Diagnostic For Lynparza In Patients With Germline BRCA-mutated Metastatic Pancreatic Cancer

Benzinga · 12/30/2019 12:07